Author | Gail E. Darling, MD

Articles

Improving Outcomes in Resectable Gastric Cancer: A Review of Current and Future Strategies

July 15, 2016

ByBryan A. Chan, BPharm, MBBS|Raymond W. Jang, MD, MSc|Rebecca K. S. Wong, MSc, MD|Carol J. Swallow, MD, PhD|Gail E. Darling, MD|Elena Elimova, MD, MSc

Here we review the evidence supporting current approaches to resectable gastric cancer, including discussion of the optimal extent of surgery and lymphadenectomy, adjuvant chemotherapy, postoperative chemotherapy with chemoradiation, and perioperative chemotherapy.